Sonia G. J.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- A Phase II Randomized, Double-Blind Study Comparing Fulvestrant and Palbociclib Versus Fulvestrant and Placebo in HR-Positive Metastatic Breast Cancer
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in High-Risk HER2-Positive Breast Cancer with Residual Disease
Data & Insights
Has run more than one trial at 11 of 157 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in advanced treatments for HER2-positive breast cancer and hormone receptor-positive metastatic breast cancer, with particular emphasis on targeted therapeutic approaches.
- High-risk HER2-positive breast cancer management
- Post-neoadjuvant therapy interventions
- Metastatic breast cancer treatment strategies
Their research encompasses innovative therapeutic combinations for breast cancer treatment, including novel antibody-drug conjugates and hormone therapy approaches.
Targeted Therapies
The investigator focuses on evaluating targeted therapeutic agents including trastuzumab derivatives and CDK4/6 inhibitors for breast cancer treatment.
- Antibody-drug conjugate therapy
- Hormone receptor targeting
- Combination therapy approaches
Their work explores the effectiveness of various therapeutic combinations in treating different breast cancer subtypes.
Endocrine Therapy
The investigator studies long-term endocrine therapy and its applications in postmenopausal breast cancer patients, particularly focusing on treatment strategies for hormone receptor-positive disease.
- First-line treatment optimization
- Extended endocrine therapy outcomes
- Treatment sequencing strategies
Their research includes assessment of treatment efficacy in patients with varied endocrine therapy exposure and disease progression patterns.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.